Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Avadel Pharmaceuticals (Nasdaq: AVDL), a biopharmaceutical company, has announced its participation in three upcoming investor conferences in September 2024:
- 2024 Wells Fargo Healthcare Conference: Fireside chat on September 4 at 3:45 p.m. ET
- Morgan Stanley 22nd Annual Global Healthcare Conference: Fireside chat on September 6 at 10:00 a.m. ET
- H.C. Wainwright 25th Annual Global Investment Conference: Fireside chat on September 11 at 11:30 a.m. ET
Live webcasts and archived recordings of these events will be available on Avadel's Investor Relations website for 90 days following each conference.
Avadel Pharmaceuticals (Nasdaq: AVDL), un'azienda biofarmaceutica, ha annunciato la sua partecipazione a tre prossimi convegni per investitori a settembre 2024:
- 2024 Wells Fargo Healthcare Conference: Discussione informale il 4 settembre alle 15:45 ET
- Morgan Stanley 22nd Annual Global Healthcare Conference: Discussione informale il 6 settembre alle 10:00 ET
- H.C. Wainwright 25th Annual Global Investment Conference: Discussione informale l'11 settembre alle 11:30 ET
Le trasmissioni in diretta e le registrazioni archiviate di questi eventi saranno disponibili sul sito web delle Relazioni con gli Investitori di Avadel per 90 giorni dopo ciascun convegno.
Avadel Pharmaceuticals (Nasdaq: AVDL), una compañía biofarmacéutica, ha anunciado su participación en tres próximas conferencias para inversores en septiembre de 2024:
- 2024 Wells Fargo Healthcare Conference: Charla informal el 4 de septiembre a las 3:45 p.m. ET
- Morgan Stanley 22nd Annual Global Healthcare Conference: Charla informal el 6 de septiembre a las 10:00 a.m. ET
- H.C. Wainwright 25th Annual Global Investment Conference: Charla informal el 11 de septiembre a las 11:30 a.m. ET
Las transmisiones en vivo y las grabaciones archivadas de estos eventos estarán disponibles en el sitio web de Relaciones con Inversores de Avadel durante 90 días después de cada conferencia.
Avadel Pharmaceuticals (Nasdaq: AVDL), 생명공학 제약 회사가 2024년 9월에 있을 3개의 투자자 회의에 참여할 것이라고 발표했습니다:
- 2024 웰스파고 헬스케어 콘퍼런스: 9월 4일 오후 3:45 ET에 진행되는 대담
- 모건 스탠리 제22회 연례 글로벌 헬스케어 콘퍼런스: 9월 6일 오전 10:00 ET에 진행되는 대담
- H.C. 웨인라이트 제25회 연례 글로벌 투자 콘퍼런스: 9월 11일 오전 11:30 ET에 진행되는 대담
이벤트의 라이브 웹캐스트와 기록된 자료는 각 콘퍼런스 종료 후 90일 동안 Avadel의 투자자 관계 웹사이트에서 이용 가능합니다.
Avadel Pharmaceuticals (Nasdaq: AVDL), une société biopharmaceutique, a annoncé sa participation à trois futures conférences pour investisseurs en septembre 2024 :
- 2024 Wells Fargo Healthcare Conference : Discussion informelle le 4 septembre à 15h45 ET
- Morgan Stanley 22e Conférence Annuelle Mondiale sur la Santé : Discussion informelle le 6 septembre à 10h00 ET
- H.C. Wainwright 25e Conférence Annuelle Mondiale sur l'Investissement : Discussion informelle le 11 septembre à 11h30 ET
Les webdiffusions en direct et les enregistrements archivés de ces événements seront disponibles sur le site des Relations Investisseurs d'Avadel pendant 90 jours après chaque conférence.
Avadel Pharmaceuticals (Nasdaq: AVDL), ein biopharmazeutisches Unternehmen, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im September 2024 angekündigt:
- 2024 Wells Fargo Healthcare Conference: Gespräch am 4. September um 15:45 Uhr ET
- Morgan Stanley 22. jährliche globale Gesundheitskonferenz: Gespräch am 6. September um 10:00 Uhr ET
- H.C. Wainwright 25. jährliche globale Investitionskonferenz: Gespräch am 11. September um 11:30 Uhr ET
Live-Webcasts und aufgezeichnete Übertragungen dieser Veranstaltungen sind auf der Investor-Relations-Website von Avadel für 90 Tage nach jeder Konferenz verfügbar.
- None.
- None.
DUBLIN, Ireland, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:
- 2024 Wells Fargo Healthcare Conference: Fireside chat on Wednesday, September 4 at 3:45 p.m. ET.
- Morgan Stanley 22nd Annual Global Healthcare Conference: Fireside chat on Friday, September 6 at 10:00 a.m. ET.
- H.C. Wainwright 25th Annual Global Investment Conference: Fireside chat on Wednesday, September 11 at 11:30 a.m. ET.
A live webcast of these events, as well as archived recordings, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following each conference.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com.
Investor Contact:
Courtney Mogerley
Precision AQ
Courtney.Mogerley@precisionAQ.com
(212) 698-8687
Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162
FAQ
What investor conferences will Avadel Pharmaceuticals (AVDL) attend in September 2024?
When is Avadel Pharmaceuticals' (AVDL) fireside chat at the 2024 Wells Fargo Healthcare Conference?
Where can investors access the webcasts of Avadel Pharmaceuticals' (AVDL) conference presentations?
How long will the recordings of Avadel Pharmaceuticals' (AVDL) conference presentations be available?
